C. Pachuk

发表

Endothelial damage inhibitors for improvement of saphenous vein graft patency in coronary artery bypass grafting: current evidence, clinical challenges and future directions.

M. Emmert, S. Sandner, E. Caliskan, 2020, Minerva cardioangiologica.

Development of a sensitive ELISA to quantify apolipoprotein CIII in nonhuman primate serum

R. Subramanian, Zhili Song, C. Pachuk, 2011, Journal of Lipid Research.

Expression and immune response to hepatitis C virus core DNA–based vaccine constructs

V. Zurawski, D. Weiner, J. Wands, 1996, Hepatology.

Intraoperative storage of saphenous vein grafts in coronary artery bypass grafting

M. Emmert, S. Rushton-Smith, C. Pachuk, 2019, Expert review of medical devices.

Preservation solutions to improve graft patency: The devil is in the detail

M. Emmert, L. Perrault, E. Caliskan, 2020, Journal of Cardiothoracic Surgery.

Detection of mouse hepatitis virus nonstructural proteins using antisera directed against bacterial viral fusion proteins.

P. Zoltick, S. Weiss, J. Leibowitz, 1990, Advances in experimental medicine and biology.

LFA-3 plasmid DNA enhances Ag-specific humoral- and cellular-mediated protective immunity against herpes simplex virus-2 in vivo: involvement of CD4+ T cells in protection.

J. Kim, D. Weiner, J. Sin, 2000, Cellular immunology.

Induction of HSV-gD2 specific CD4(+) cells in Peyer's patches and mucosal antibody responses in mice following DNA immunization by both parenteral and mucosal administration.

C. Satishchandran, L. A. Snyder, K. E. Shroff, 1999, Vaccine.

Preclinical safety of DNA vaccines : a method to analyze the distribution of plasmid DNA in animal models.

C. Satishchandran, R. Ciccarelli, C. Pachuk, 2000, Methods in molecular medicine.

DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model.

D. Weiner, J. Sin, M. Bagarazzi, 1999, DNA and cell biology.

Humoral and cellular immune responses to herpes simplex virus-2 glycoprotein D generated by facilitated DNA immunization of mice.

R. Ciccarelli, C. Pachuk, T. Higgins, 1998, Current topics in microbiology and immunology.

Herpes simplex virus DNA vaccine efficacy: effect of glycoprotein D plasmid constructs.

D. Bernstein, J. E. Strasser, C. Pachuk, 2000, The Journal of infectious diseases.

Facilitated DNA inoculation induces anti-HIV-1 immunity in vivo.

V. Srikantan, K. Ugen, J. Boyer, 1994, Vaccine.

DNA vaccines--challenges in delivery.

D. Weiner, C. Satishchandran, D. Mccallus, 2000, Current opinion in molecular therapeutics.

IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge.

J. Kim, D. Weiner, J. Sin, 1999, Journal of immunology.

Challenge Immunity Against Herpes Simplex Virus-2 T Cell-Mediated Protective + Th 1-Type CD 4 Herpes Mouse Model : IL-12 Enhances IL-12 Gene as a DNA Vaccine Adjuvant in a

D. Weiner, J. Sin, K. E. Shroff, 1999 .

Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses.

K. E. Shroff, C. Pachuk, T. Higgins, 2000, The Journal of infectious diseases.

RNA Interference and Its Potential Applications to Chronic HBV Treatment: Results of a Phase I Safety and Tolerability Study

R. Gish, C. Satishchandran, C. Pachuk, 2011, Antiviral therapy.

Using RNA interference to modulate gene expression

T. Giordano, C. Satishchandran, M. Chopra, 2002 .

Methods for DNA introduction into mammalian cells

P. Norton, C. Pachuk, 2003 .

RNA interference-mediated prevention and therapy for hepatocellular carcinoma

P. Romano, D. Mccallus, C. Pachuk, 2006, Oncogene.

Vector design for liver-specific expression of multiple interfering RNAs that target hepatitis B virus transcripts.

L. Steel, Lindsey L. Snyder, L. L. Snyder, 2008, Antiviral research.

Characterization of a new class of DNA delivery complexes formed by the local anesthetic bupivacaine.

V. Zurawski, D. Weiner, D. Zurawski, 2000, Biochimica et biophysica acta.

Administration in vivo d'arn double brin à une cellule cible

C. Pachuk, 2007 .

The primary structure and expression of the second open reading frame of the polymerase gene of the coronavirus MHV-A59; a highly conserved polymerase is expressed by an efficient ribosomal frameshifting mechanism.

S. Weiss, W. Spaan, P. Bredenbeek, 1990, Nucleic acids research.

DNA Vaccines Encoding Interleukin-8 and RANTES Enhance Antigen-Specific Th1-Type CD4+ T-Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 In Vivo

D. Weiner, J. Sin, C. Satishchandran, 2000, Journal of Virology.

Molecular cloning of the gene encoding the putative polymerase of mouse hepatitis coronavirus, strain A59

P. Zoltick, S. Weiss, W. Spaan, 1989, Virology.

A spectrophotometric method to quantify linear DNA.

C. Satishchandran, Meiqing Lu, C. Pachuk, 2003, Analytical biochemistry.

Chain reaction cloning: a one-step method for directional ligation of multiple DNA fragments.

C. Satishchandran, C J Pachuk, M Samuel, 2000, Gene.

Selective cleavage of bcr-abl chimeric RNAs by a ribozyme targeted to non-contiguous sequences.

K. Moelling, K. Yoon, L. Coney, 1994, Nucleic acids research.

Identification of polypeptides encoded in open reading frame 1b of the putative polymerase gene of the murine coronavirus mouse hepatitis virus A59

P. Zoltick, S. Weiss, M. Denison, 1991, Journal of virology.